287 related articles for article (PubMed ID: 32434738)
1. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis.
Matiollo C; Rateke ECM; de Oliveira KG; Turnes BL; da Silva TE; Maccali C; Latini AS; Narciso-Schiavon JL; Schiavon LL
Dig Liver Dis; 2020 Jul; 52(7):753-760. PubMed ID: 32434738
[TBL] [Abstract][Full Text] [Related]
2. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
[TBL] [Abstract][Full Text] [Related]
3. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Yan H; Jin S; Liang L; Du J; Aithal GP; Li L
Scand J Gastroenterol; 2020 May; 55(5):606-614. PubMed ID: 32476510
[No Abstract] [Full Text] [Related]
4. Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.
Ruiz-Margáin A; Pohlmann A; Ryan P; Schierwagen R; Chi-Cervera LA; Jansen C; Mendez-Guerrero O; Flores-García NC; Lehmann J; Torre A; Macías-Rodríguez RU; Trebicka J
Liver Transpl; 2018 May; 24(5):595-605. PubMed ID: 29476704
[TBL] [Abstract][Full Text] [Related]
5. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
[TBL] [Abstract][Full Text] [Related]
6. Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis.
Silva PE; Fayad L; Lazzarotto C; Ronsoni MF; Bazzo ML; Colombo BS; Dantas-Correa EB; Narciso-Schiavon JL; Schiavon LL
Liver Int; 2015 May; 35(5):1516-23. PubMed ID: 24840673
[TBL] [Abstract][Full Text] [Related]
7. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure.
Mani I; Alexopoulou A; Vasilieva L; Hadziyannis E; Agiasotelli D; Bei M; Alexopoulos T; Dourakis SP
Liver Int; 2019 Feb; 39(2):299-306. PubMed ID: 30261128
[TBL] [Abstract][Full Text] [Related]
8. Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure.
Alexopoulou A; Vasilieva L; Mani I; Agiasotelli D; Pantelidaki H; Dourakis SP
Scand J Gastroenterol; 2017 Dec; 52(12):1385-1390. PubMed ID: 28851246
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.
Narciso-Schiavon JL; Pereira JG; Silva TE; Bansho ETO; Morato EF; Pinheiro JT; Muraro-Wildner L; Bazzo ML; Dantas-Corrêa EB; Schiavon LL
Ann Hepatol; 2017; 16(5):780-787. PubMed ID: 28809733
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
Grønbæk H; Rødgaard-Hansen S; Aagaard NK; Arroyo V; Moestrup SK; Garcia E; Solà E; Domenicali M; Piano S; Vilstrup H; Møller HJ;
J Hepatol; 2016 Apr; 64(4):813-22. PubMed ID: 26639396
[TBL] [Abstract][Full Text] [Related]
11. Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.
Bernsmeier C; Cavazza A; Fatourou EM; Theocharidou E; Akintimehin A; Baumgartner B; Dhar A; Auzinger G; Thursz M; Bernal W; Wendon JA; Karvellas CJ; Antoniades CG; McPhail MJW
Aliment Pharmacol Ther; 2020 Sep; 52(5):855-865. PubMed ID: 32683724
[TBL] [Abstract][Full Text] [Related]
12. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
Grønbaek H; Møller HJ; Saliba F; Zeuzem S; Albillos A; Ariza X; Graupera I; Solà E; Amoros A; Pavesi M; Bossen L; Jalan R; Gines P; Arroyo V
J Gastroenterol Hepatol; 2021 Jan; 36(1):240-248. PubMed ID: 32478437
[TBL] [Abstract][Full Text] [Related]
13. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality.
Mücke MM; Rumyantseva T; Mücke VT; Schwarzkopf K; Joshi S; Kempf VAJ; Welsch C; Zeuzem S; Lange CM
Liver Int; 2018 Apr; 38(4):645-653. PubMed ID: 28853199
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiles in serum samples from Acute-On-Chronic Liver Failure patients and miR-25-3p as a potential biomarker for survival prediction.
Cisilotto J; do Amaral AE; Rosolen D; Rode MP; Silva AH; Winter E; da Silva TE; Fischer J; Matiollo C; Rateke ECM; Narciso-Schiavon JL; Schiavon LL; Creczynski-Pasa TB
Sci Rep; 2020 Jan; 10(1):100. PubMed ID: 31919459
[TBL] [Abstract][Full Text] [Related]
15. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.
Horvatits T; Drolz A; Roedl K; Rutter K; Ferlitsch A; Fauler G; Trauner M; Fuhrmann V
Liver Int; 2017 Feb; 37(2):224-231. PubMed ID: 27416294
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhotic patients with acute-on-chronic liver failure.
Chiriac S; Stanciu C; Singeap AM; Sfarti CV; Cuciureanu T; Trifan A
Turk J Gastroenterol; 2020 Dec; 31(12):868-876. PubMed ID: 33625999
[TBL] [Abstract][Full Text] [Related]
17. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).
Mezzano G; Cárdenas A; Aguilar F; Pavesi M; Solé C; Napoleone L; Graupera I; Juanola A; Carol M; Pose E; Fabrellas N; Hernaez R; Martínez J; Saliba F; Arroyo V; Sola E; Gines P
Dig Liver Dis; 2021 Jun; 53(6):738-745. PubMed ID: 33446445
[TBL] [Abstract][Full Text] [Related]
18. Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection.
Lopes-Secundo TM; Sevá-Pereira T; Correa BR; Silva NCM; Imbrizi MR; Cunha-Silva M; Soares EC; Almeida JRS
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1055-1059. PubMed ID: 29944488
[TBL] [Abstract][Full Text] [Related]
19. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
[TBL] [Abstract][Full Text] [Related]
20. Acute-on-chronic liver failure: A comparison of three different diagnostic criteria.
Leão GS; Lunardi FL; Picon RV; Tovo CV; de Mattos AA; de Mattos ÂZ
Ann Hepatol; 2019; 18(2):373-378. PubMed ID: 31053547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
